Vivos in The News Explore The Stories Investor RelationsLeadershipFinancial Results & SEC FilingsStock PricingGovernanceNews + Events Menu Investor RelationsLeadershipFinancial Results & SEC FilingsStock PricingGovernanceNews + Events Listen to the live Webcast March 28th at 5:00 pm ET Vivos Reports 1st Quarter 2023 Financial Results & Operational Update Vivos Schedules Release of First Quarter 2023 Financial Results and Conference Call Vivos Announces Strategic Initiatives Aimed at Accelerating Timeline for Cash Flow Positive Operations Clinical Study Shows 92% Resolution of Migraines Using Vivos’ POD® Vivos Reports Fourth Quarter & Full Year 2022 Financial Results & Operational Update Vivos Therapeutics to Participate in Fireside Chat at the 35th Annual ROTH Conference Vivos Expands Revenue Potential with Acquisition of Product Rights & Patents from Advanced Facialdontics Vivos Therapeutics to Present at the Emerging Growth Conference Vivos Therapeutics Regains Compliance with Nasdaq Listing Requirements Load More
Vivos Announces Strategic Initiatives Aimed at Accelerating Timeline for Cash Flow Positive Operations
Vivos Expands Revenue Potential with Acquisition of Product Rights & Patents from Advanced Facialdontics